Cell Growth & Differentiation, Vol 1, Issue 11 519-526, Copyright © 1990 by American Association of Cancer Research

ARTICLES

An exogenous albumin promoter can become silent in dedifferentiated hepatoma variants as well as intertypic hybrids

PO Angrand, S Kallenbach, MC Weiss and JP Rousset
Departement de Biologie Moleculaire, URA 1149 du Centre National de la Recherche Scientifique, Institut Pasteur, Paris, France.

In order to evaluate the ability of an exogenous tissue-specific promoter to undergo the same dynamic changes in activity as the endogenous one, a 400-base pair fragment of the rat albumin proximal promoter, upstream of the bacterial gpt gene, has been introduced into rat hepatoma cells. Four clones containing a single integrated copy of the construct and producing substantial amounts of albumin and of xanthine phosphoribosyltransferase were isolated. These clones were subjected to two treatments known to result in silencing of the albumin gene: selection for dedifferentiated variants, and fusion with L-cell fibroblasts. In most cases, the albumin-negative progeny obtained no longer expressed the gpt gene: the exogenous promoter of 400 base pairs must contain the sequences required to respond to the mechanisms that block activity of the endogenous gene. However, exceptions were observed: the albumin-deficient variants of one clone remained xanthine phosphoribosyltransferase positive, and some of the albumin-negative hybrids from a different clone continued to produce xanthine phosphoribosyltransferase. These cases of dissociation in expression of the endogenous and the exogenous genes indicate that the site of integration of the alb-gpt construct in one clone renders the sequences insensitive to the mechanisms responsible for albumin gene silencing in dedifferentiated variants, and in the other clone to the mechanism of extinction. Consequently, the mechanisms causing gene silencing in variants and in intertypic hybrids must be different.

This article has been cited by other articles:

				R. Singhal, T. M. Badger, and M. J. Ronis Reduction in 7,12-Dimethylbenz[a]anthracene-Induced Hepatic Cytochrome-P450 1A1 Expression Following Soy Consumption in Female Rats Is Mediated by Degradation of the Aryl Hydrocarbon Receptor J. Nutr., January 1, 2007; 137(1): 19 - 24. [Abstract] [Full Text] [PDF]

				N. Briancon, A. Bailly, F. Clotman, P. Jacquemin, F. P. Lemaigre, and M. C. Weiss Expression of the {alpha}7 Isoform of Hepatocyte Nuclear Factor (HNF) 4 Is Activated by HNF6/OC-2 and HNF1 and Repressed by HNF4{alpha}1 in the Liver J. Biol. Chem., August 6, 2004; 279(32): 33398 - 33408. [Abstract] [Full Text] [PDF]

				A. Bailly, M. E. Torres-Padilla, A. P. Tinel, and M. C. Weiss An enhancer element 6 kb upstream of the mouse HNF4{alpha}1 promoter is activated by glucocorticoids and liver-enriched transcription factors Nucleic Acids Res., September 1, 2001; 29(17): 3495 - 3505. [Abstract] [Full Text] [PDF]

				G. F. Spath and M. C. Weiss Hepatocyte Nuclear Factor 4 Provokes Expression of Epithelial Marker Genes, Acting As a Morphogen in Dedifferentiated Hepatoma Cells J. Cell Biol., February 23, 1998; 140(4): 935 - 946. [Abstract] [Full Text] [PDF]

				A Bailly, G Spath, V Bender, and M. Weiss Phenotypic effects of the forced expression of HNF4 and HNF1alpha are conditioned by properties of the recipient cell J. Cell Sci., January 8, 1998; 111(16): 2411 - 2421. [Abstract] [PDF]

				P. O. Angrand, J. P. Rousset, and M. C. Weiss Cell phenotype, binding affinity and promoter structure modulate transactivation by HNF1 and LAP J. Cell Sci., December 1, 1992; 103(4): 1083 - 1092. [Abstract] [PDF]